Inhaled milrinone for pulmonary hypertension in high-risk cardiac surgery: silver bullet or just part of a broader management strategy?

Can J Anaesth. 2016 Oct;63(10):1122-1127. doi: 10.1007/s12630-016-0708-9. Epub 2016 Jul 29.

Authors

Joseph Bednarczyk¹, Johann Strumpher^{2

3}, Eric Jacobsohn^{2

3}

Affiliations

¹ Section of Critical Care, Department of Medicine, Health Sciences Centre, University of Manitoba, Room GC425, 820 Sherbrook Street, Winnipeg, MB, R3T 2N2, Canada. joseph.bednarczyk@gmail.com.
² Section of Critical Care, Department of Medicine, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada.
³ Department of Anesthesia and Perioperative Medicine, St. Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada.

PMID: 27473721
DOI: 10.1007/s12630-016-0708-9

No abstract available

Publication types

Editorial

MeSH terms

Administration, Inhalation
Cardiac Surgical Procedures / methods*
Humans
Hypertension, Pulmonary / drug therapy*
Milrinone / administration & dosage*
Milrinone / therapeutic use*
Risk
Vasodilator Agents / administration & dosage*
Vasodilator Agents / therapeutic use*

Substances

Vasodilator Agents
Milrinone